Complete Filing Data
Milestone Pharmaceuticals Inc. reported Stockholders Equity of $41.77 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Milestone Pharmaceuticals Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$63.1M | -$41.5M | -$59.7M | -$58.4M | -$42.9M | -$50.0M | -$55.2M | -$23.2M |
| Research And Development Expense | $18.1M | $14.4M | $31.1M | $39.8M | $38.7M | $34.5M | $42.0M | $16.8M |
| Operating Income Loss | -$62.1M | -$42.1M | -$61.1M | -$59.6M | -$43.1M | -$50.7M | -$57.9M | -$23.8M |
| General And Administrative Expense | $17.3M | $16.7M | $15.9M | $15.7M | $12.4M | $10.3M | $7.0M | $3.1M |
| Tax Credits Receivable Research And Development | $316.0K | $901.0K | $643.0K | $331.0K | $356.0K | $725.0K | $578.0K | $290.0K |
| Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer | $1.5M | $0.00 | $1.0M | $5.0M | $15.0M | |||
| Investment Income Nonoperating | $220.0K | $726.0K | $2.6M | $711.0K | ||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$50.0M | -$55.3M | -$23.1M | |||||
| Income Tax Expense Benefit | -$17.0K | -$56.0K | $74.0K | |||||
| Interest Expense Nonoperating | $3.8M | $3.6M | $2.6M | |||||
| Interest Income Expense Nonoperating Net | $4.0M | $1.3M | $220.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$11.9M | -$13.0M | -$20.8M | -$9.4M | -$9.4M | -$10.4M | -$15.1M | -$16.0M | -$15.0M | -$14.6M | -$16.6M | -$14.0M | -$14.2M | $770.0K | -$12.5M | -$12.0M | -$13.0M | -$16.3M | -$12.8M | -$13.7M | -$10.5M | -$5.7M | -$3.6M | -$4.2M |
| Research And Development Expense | $3.9M | $3.7M | $5.0M | $4.0M | $2.8M | $3.6M | $6.7M | $8.6M | $10.3M | $9.8M | $10.7M | $8.8M | $9.7M | $9.4M | $8.6M | $8.2M | $8.6M | $11.9M | $9.5M | $10.5M | $7.8M | $3.9M | $2.6M | $3.1M |
| Operating Income Loss | -$11.8M | -$12.5M | -$20.5M | -$9.6M | -$9.7M | -$10.5M | -$15.4M | -$16.4M | -$15.5M | -$15.0M | -$16.8M | -$14.0M | -$14.3M | $712.0K | -$12.6M | -$12.1M | -$13.1M | -$16.8M | -$13.7M | -$14.3M | -$10.9M | -$5.8M | -$3.7M | -$4.3M |
| General And Administrative Expense | $3.3M | $3.8M | $5.2M | $3.7M | $5.0M | $4.0M | $4.2M | $4.4M | $3.9M | $4.0M | $3.9M | $3.6M | $3.0M | $3.0M | $2.6M | $3.0M | $3.0M | $2.7M | $2.1M | $1.6M | $979.0K | $646.0K | $750.0K | $439.0K |
| Tax Credits Receivable Research And Development | $808.0K | $1.1M | $994.0K | $837.0K | $776.0K | $711.0K | $569.0K | $483.0K | $414.0K | $195.0K | $539.0K | $412.0K | $275.0K | $903.0K | $816.0K | $822.0K | $530.0K | $684.0K | $456.0K | $357.0K | $264.0K | |||
| Revenue From Collaborative Arrangement Excluding Revenue From Contract With Customer | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.0M | $1.5M | $0.00 | $15.0M | ||||||||||||
| Investment Income Nonoperating | $40.0K | $48.0K | $58.0K | $80.0K | $89.0K | $126.0K | $415.0K | $821.0K | $672.0K | $500.0K | $85.0K | $89.0K | $90.0K | |||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$12.0M | -$13.0M | -$16.3M | -$12.9M | -$13.7M | -$10.4M | -$5.7M | -$3.6M | -$4.2M | |||||||||||||||
| Income Tax Expense Benefit | -$17.0K | -$73.0K | -$4.0K | $22.0K | $2.0K | $16.0K | ||||||||||||||||||
| Interest Expense Nonoperating | $967.0K | $951.0K | $935.0K | $903.0K | $887.0K | $872.0K | $841.0K | $820.0K | ||||||||||||||||
| Interest Income Expense Nonoperating Net | $552.0K | $474.0K | $158.0K | $40.0K | $48.0K | $58.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $41.8M | $13.1M | $16.8M | $66.3M | $112.6M | $143.1M | $114.9M | $83.5M | $26.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $73.0M | $25.3M | $13.8M | $7.6M | $114.1M | $72.3M | $119.8M | ||
| Operating Lease Right Of Use Asset | $1.1M | $1.4M | $1.9M | $2.4M | $711.0K | $980.0K | $524.0K | $321.0K | |
| Retained Earnings Accumulated Deficit | -$430.6M | -$367.5M | -$326.0M | -$266.3M | -$208.0M | -$163.5M | -$113.5M | -$58.3M | |
| Property Plant And Equipment Net | $511.0K | $197.0K | $277.0K | $257.0K | $215.0K | $308.0K | $405.0K | $30.0K | |
| Other Receivables Net Current | $1.6M | $1.5M | $3.2M | $882.0K | $127.0K | $223.0K | $258.0K | $387.0K | |
| Liabilities Current | $14.0M | $8.1M | $7.2M | $6.1M | $6.8M | $6.2M | $8.3M | $4.5M | |
| Liabilities And Stockholders Equity | $113.6M | $75.5M | $75.2M | $74.5M | $119.8M | $150.0M | $123.4M | $88.1M | |
| Liabilities | $71.8M | $62.4M | $58.5M | $8.1M | $7.2M | $6.9M | $8.5M | $4.5M | |
| Common Stock Value | $352.6M | $288.0M | $260.5M | $273.9M | $251.9M | $251.7M | $226.2M | $2.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $47.7M | $11.6M | $6.1M | -$106.5M | $41.8M | -$47.5M | $33.9M | $75.1M | |
| Cash And Cash Equivalents At Carrying Value | $73.0M | $25.3M | $13.8M | $7.6M | $114.1M | $72.3M | $119.8M | $85.9M | |
| Assets Current | $111.9M | $73.9M | $73.0M | $71.8M | $118.9M | $148.7M | $122.5M | $88.1M | |
| Assets | $113.6M | $75.5M | $75.2M | $74.5M | $119.8M | $150.0M | $123.4M | $88.1M | |
| Accounts Payable And Accrued Liabilities Current | $13.3M | $7.6M | $6.7M | $5.6M | $6.6M | $5.9M | $8.0M | $4.5M | |
| Operating Lease Liability Noncurrent | $539.0K | $874.0K | $1.5M | $2.0M | $474.0K | $696.0K | $184.0K | ||
| Operating Lease Liability Current | $647.0K | $571.0K | $546.0K | $495.0K | $224.0K | $245.0K | $330.0K | ||
| Short Term Investments | $32.9M | $44.4M | $52.2M | $56.9M | $0.00 | $70.0M | $29.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $85.9M | $10.9M | |||||||
| Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax | -$1.6M | -$1.6M | -$1.6M | ||||||
| Long Term Debt | $57.2M | $53.4M | $49.8M | ||||||
| Total Equity Including Temporary Equity And Stockholders Equity Attributable To Parent |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $20.5M | -$17.7M | -$6.1M | $24.0M | $32.0M | $39.9M | $28.5M | $40.4M | $53.9M | $77.2M | $86.7M | $100.8M | $127.4M | $139.6M | $132.0M | $102.2M | $88.0M | $99.6M | $132.8M | $145.3M | $73.3M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $46.7M | $42.5M | $45.1M | $12.8M | $13.3M | $10.1M | $9.9M | $32.6M | $74.0M | $37.3M | $63.2M | $92.2M | $111.4M | $97.8M | $71.9M | $46.9M | $53.4M | ||||||||||||
| Operating Lease Right Of Use Asset | $944.0K | $1.1M | $1.2M | $1.5M | $1.7M | $1.8M | $2.0M | $2.2M | $2.3M | $2.5M | $570.0K | $641.0K | $780.0K | $847.0K | $914.0K | $1.0M | $377.0K | $451.0K | $593.0K | $243.0K | $282.0K | ||||||||
| Retained Earnings Accumulated Deficit | -$413.2M | -$401.3M | -$388.3M | -$355.2M | -$345.7M | -$336.4M | -$312.4M | -$297.3M | -$281.3M | -$251.5M | -$237.0M | -$220.3M | -$189.4M | -$175.2M | -$176.0M | -$154.8M | -$142.8M | -$129.8M | -$95.2M | -$82.4M | -$68.7M | ||||||||
| Property Plant And Equipment Net | $136.0K | $159.0K | $176.0K | $201.0K | $222.0K | $249.0K | $272.0K | $278.0K | $272.0K | $303.0K | $227.0K | $192.0K | $238.0K | $262.0K | $285.0K | $333.0K | $356.0K | $381.0K | $328.0K | $43.0K | $27.0K | ||||||||
| Other Receivables Net Current | $700.0K | $924.0K | $1.2M | $1.2M | $1.6M | $1.4M | $1.5M | $1.1M | $694.0K | $435.0K | $261.0K | $245.0K | $89.0K | $242.0K | $277.0K | $183.0K | $318.0K | $259.0K | $497.0K | $338.0K | $265.0K | ||||||||
| Liabilities Current | $10.5M | $9.3M | $13.0M | $5.3M | $4.6M | $4.1M | $8.1M | $6.8M | $8.0M | $6.5M | $4.3M | $4.6M | $5.8M | $5.3M | $5.8M | $5.9M | $5.0M | $5.4M | $8.8M | $6.5M | $4.2M | ||||||||
| Liabilities And Stockholders Equity | $87.8M | $47.4M | $61.9M | $82.7M | $89.2M | $96.0M | $87.1M | $97.0M | $111.1M | $85.8M | $91.3M | $105.8M | $133.8M | $145.5M | $138.4M | $108.8M | $93.1M | $105.2M | $141.9M | $151.8M | $77.6M | ||||||||
| Liabilities | $67.2M | $65.2M | $68.0M | $58.7M | $57.3M | $56.1M | $58.6M | $56.6M | $57.1M | $8.6M | $4.6M | $5.0M | $6.4M | $5.9M | $6.5M | $6.6M | $5.1M | $5.5M | $9.1M | $6.5M | $4.3M | ||||||||
| Common Stock Value | $311.8M | $288.3M | $288.2M | $288.0M | $287.9M | $287.9M | $260.5M | $260.2M | $260.1M | $254.9M | $252.2M | $252.0M | $251.8M | $251.7M | $251.7M | $226.8M | $226.7M | $226.4M | $226.2M | $226.2M | $2.1M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $19.8M | -$3.6M | $66.3M | -$21.9M | -$451.0K | -$18.0M | -$14.7M | $2.3M | |||||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $46.7M | $42.5M | $45.1M | $12.8M | $13.3M | $10.1M | $9.9M | $32.6M | $74.0M | $37.3M | $63.2M | $92.2M | $111.4M | $97.8M | $71.9M | $46.9M | $53.4M | $101.8M | $106.5M | $110.8M | $71.2M | ||||||||
| Assets Current | $86.7M | $46.2M | $60.5M | $81.0M | $87.4M | $94.0M | $84.8M | $94.6M | $108.5M | $82.9M | $90.5M | $105.0M | $132.8M | $144.4M | $137.2M | $107.4M | $92.4M | $104.3M | $141.0M | $151.6M | $77.3M | ||||||||
| Assets | $87.8M | $47.4M | $61.9M | $82.7M | $89.2M | $96.0M | $87.1M | $97.0M | $111.1M | $85.8M | $91.3M | $105.8M | $133.8M | $145.5M | $138.4M | $108.8M | $93.1M | $105.2M | $141.9M | $151.8M | $77.6M | ||||||||
| Accounts Payable And Accrued Liabilities Current | $10.0M | $8.8M | $12.4M | $4.7M | $4.0M | $3.6M | $7.6M | $6.3M | $7.4M | $6.0M | $4.1M | $4.4M | $5.6M | $5.1M | $5.6M | $5.6M | $4.8M | $5.2M | $8.5M | $6.3M | $3.9M | ||||||||
| Operating Lease Liability Noncurrent | $519.0K | $641.0K | $758.0K | $1.0M | $1.2M | $1.3M | $1.6M | $1.7M | $1.9M | $2.1M | $384.0K | $433.0K | $512.0K | $573.0K | $635.0K | $718.0K | $132.0K | $158.0K | $224.0K | $61.0K | $104.0K | ||||||||
| Operating Lease Liability Current | $483.0K | $515.0K | $542.0K | $582.0K | $567.0K | $555.0K | $530.0K | $522.0K | $507.0K | $487.0K | $169.0K | $198.0K | $254.0K | $259.0K | $252.0K | $234.0K | $157.0K | $196.0K | $358.0K | $175.0K | $168.0K | ||||||||
| Short Term Investments | $35.9M | $918.0K | $10.9M | $63.6M | $70.0M | $79.4M | $65.9M | $55.0M | $27.0M | $39.9M | $23.0M | $8.0M | $15.0M | $38.0M | $58.0M | $56.0M | $32.0M | $30.0M | $35.0M | $29.0K | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $71.9M | $72.3M | $46.9M | $53.4M | $101.8M | $119.8M | $106.5M | $110.8M | $71.2M | $4.2M | $17.8M | $13.2M | |||||||||||||||||
| Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax | -$1.6M | -$1.6M | -$1.6M | -$1.6M | -$1.6M | -$1.6M | -$1.6M | -$1.6M | -$1.6M | -$1.6M | -$1.6M | -$1.6M | -$1.6M | ||||||||||||||||
| Long Term Debt | $56.2M | $55.2M | $54.3M | $52.4M | $51.5M | $50.6M | $48.9M | $48.1M | $47.3M | ||||||||||||||||||||
| Total Equity Including Temporary Equity And Stockholders Equity Attributable To Parent | $132.8M | $145.3M | $73.3M | $83.5M | $12.8M | $18.5M | $22.0M | $26.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $7.5M | $5.8M | $9.5M | $9.0M | $7.3M | $4.9M | $1.2M | $633.0K |
| Net Cash Provided By Used In Operating Activities | -$49.0M | -$28.8M | -$46.4M | -$52.5M | -$33.2M | -$50.7M | -$51.2M | -$21.0M |
| Net Cash Provided By Used In Financing Activities | $85.5M | $32.1M | $47.8M | $3.1M | $5.1M | $73.2M | $85.4M | $80.1M |
| Increase Decrease In Research And Development Tax Credits Receivable | -$585.0K | $258.0K | $312.0K | -$25.0K | -$369.0K | $147.0K | $288.0K | -$137.0K |
| Increase Decrease In Prepaid Expense | -$29.0K | -$1.3M | -$2.8M | $1.7M | -$1.1M | $3.6M | $447.0K | $1.3M |
| Increase Decrease In Other Receivables | $156.0K | -$1.7M | $2.3M | $755.0K | -$96.0K | -$35.0K | -$119.0K | $271.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $4.4M | $875.0K | $1.0M | -$907.0K | $637.0K | -$2.1M | $3.5M | $2.9M |
| Depreciation Depletion And Amortization | $114.0K | $105.0K | $92.0K | $89.0K | $93.0K | $97.0K | $38.0K | $10.0K |
| Proceeds From Stock Options Exercised | $444.0K | $53.0K | $189.0K | $420.0K | $121.0K | $300.0K | $44.0K | $461.0K |
| Net Cash Provided By Used In Investing Activities | $11.2M | $8.3M | $4.8M | -$57.1M | $70.0M | -$70.0M | -$384.0K | $16.0M |
| Payments To Acquire Short Term Investments | $82.9M | $113.6M | $137.1M | $85.9M | $15.0M | $90.0M | $35.0M | $3.0M |
| Increase Decrease In Operating Lease Right Of Use Asset Net | -$12.0K | -$17.0K | $18.0K | $81.0K | $26.0K | -$29.0K | ||
| Payments To Acquire Property Plant And Equipment | $302.0K | $33.0K | $112.0K | $272.0K | $413.0K | $5.0K | ||
| Payments To Sale Maturity And Collection Of Short Term Investments | -$121.9M | -$142.0M | -$29.0M | |||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 300.0K | 191.0K | 393.0K | |||||
| Proceeds From Issuance Of Common Stock | $37.6M | $27.3M | $2.6M | $250.0M | $24.9M | |||
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $94.5M | $121.9M | $20.0M | $35.0M | $19.0M | |||
| Increase Decrease In Income Taxes | -$56.0K | $52.0K | ||||||
| Proceeds From Issuance Of Pre Funded Warrants Net Of Issuance Costs | $2.6M | $4.6M | ||||||
| Proceeds From Issuance Initial Public Offering | $85.4M | |||||||
| Proceeds From Convertible Debt | $50.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $1.4M | $1.5M | $2.3M | $2.1M | $1.4M | $981.0K | $211.0K | $125.0K |
| Net Cash Provided By Used In Operating Activities | -$14.0M | -$8.9M | -$13.9M | -$13.9M | -$12.5M | -$18.1M | -$14.7M | -$4.7M |
| Net Cash Provided By Used In Financing Activities | $140.0K | $32.3M | $50.3M | $49.0K | $19.0K | $77.0K | $25.0K | $30.0K |
| Increase Decrease In Research And Development Tax Credits Receivable | $93.0K | $68.0K | $83.0K | $56.0K | $91.0K | $106.0K | -$26.0K | -$119.0K |
| Increase Decrease In Prepaid Expense | $516.0K | -$816.0K | -$558.0K | -$231.0K | $864.0K | -$280.0K | $4.1M | $644.0K |
| Increase Decrease In Other Receivables | -$323.0K | -$1.8M | -$188.0K | $118.0K | $54.0K | $1.0K | -$128.0K | $25.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $4.9M | -$3.4M | -$912.0K | -$2.1M | -$350.0K | -$2.8M | -$571.0K | -$135.0K |
| Depreciation Depletion And Amortization | $27.0K | $28.0K | $18.0K | $23.0K | $23.0K | $24.0K | $3.0K | $2.0K |
| Proceeds From Stock Options Exercised | $124.0K | $49.0K | $19.0K | $77.0K | $25.0K | $30.0K | ||
| Net Cash Provided By Used In Investing Activities | $33.6M | -$27.0M | $30.0M | -$8.0M | $12.0M | $7.0M | ||
| Payments To Acquire Short Term Investments | $877.0K | $52.5M | $15.0M | $8.0M | ||||
| Increase Decrease In Operating Lease Right Of Use Asset Net | -$3.0K | -$10.0K | $1.0K | $3.0K | $12.0K | -$87.0K | ||
| Payments To Acquire Property Plant And Equipment | $6.0K | $32.0K | $5.0K | |||||
| Payments To Sale Maturity And Collection Of Short Term Investments | -$34.5M | -$25.5M | -$45.0M | -$12.0M | ||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 140.0K | 117.0K | 129.0K | |||||
| Proceeds From Issuance Of Common Stock | $27.5M | |||||||
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $12.0M | $7.0M | ||||||
| Increase Decrease In Income Taxes | $22.0K | $16.0K | ||||||
| Proceeds From Issuance Of Pre Funded Warrants Net Of Issuance Costs | -$4.7M | |||||||
| Proceeds From Issuance Initial Public Offering | ||||||||
| Proceeds From Convertible Debt | $50.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.75 | -$0.67 | -$1.39 | -$1.38 | -$1.02 | -$1.70 | -$3.50 | $72.63 |
| Common Stock Shares Outstanding | 106.2M | 53.4M | 33.5M | 34.3M | 29.9M | 29.8M | 24.5M | 596.8K |
| Common Stock Shares Issued | 106.2M | 53.4M | 33.5M | 34.3M | 29.9M | 29.8M | 24.5M | 596.8K |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Weighted Average Number Of Shares And Prefunded Warrants Outstanding Basic | 83.9M | 62.2M | 43.0M | 42.5M | 41.8M | 29.3M | ||
| Earnings Per Share Basic | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 | $-1.70 | ||
| Weighted Average Number Of Shares And Prefunded Warrants Outstanding Diluted | 83.9M | 62.2M | 43.0M | 42.5M | 41.8M | 29.3M | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 29.3M | 15.8M | 319.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | -$0.20 | -$0.31 | -$0.14 | -$0.14 | -$0.21 | -$0.35 | -$0.37 | -$0.35 | -$0.34 | -$0.39 | -$0.33 | -$0.34 | $0.02 | -$0.30 | -$0.40 | -$0.53 | -$0.67 | -$0.52 | -$1.04 | -$17.32 | -$20.16 | -$12.71 | -$15.57 | |
| Common Stock Shares Outstanding | 85.2M | 53.5M | 53.5M | 53.3M | 53.3M | 53.2M | 33.5M | 33.4M | 33.3M | 30.4M | 30.0M | 29.9M | 29.9M | 29.8M | 29.8M | 24.7M | 24.7M | 24.6M | 24.5M | 24.5M | 614.9K | ||||
| Common Stock Shares Issued | 85.2M | 53.5M | 53.5M | 53.3M | 53.3M | 53.2M | 33.5M | 33.4M | 33.3M | 30.4M | 30.0M | 29.9M | 29.9M | 29.8M | 29.8M | 24.7M | 24.7M | 24.6M | 24.5M | 24.5M | 614.9K | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares And Prefunded Warrants Outstanding Basic | 96.5M | 66.4M | 66.3M | 66.2M | 66.2M | 50.2M | 43.0M | 42.9M | 42.9M | 42.5M | 42.3M | 42.2M | 42.2M | 41.7M | 41.3M | 24.6M | |||||||||
| Earnings Per Share Basic | $-0.12 | $-0.20 | $-0.31 | $-0.14 | $-0.14 | $-0.21 | $-0.35 | $-0.37 | $-0.35 | $-0.34 | $-0.39 | $-0.33 | $-0.34 | $0.02 | $-0.30 | $-0.53 | |||||||||
| Weighted Average Number Of Shares And Prefunded Warrants Outstanding Diluted | 96.5M | 66.4M | 66.3M | 66.2M | 66.2M | 50.2M | 43.0M | 42.9M | 42.9M | 42.5M | 42.3M | 42.2M | 42.2M | 44.5M | 41.3M | ||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 41.3M | 29.8M | 24.6M | 24.5M | 24.5M | 13.2M | 603.0K | 282.8K | 282.3K | 268.5K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.5M | $5.8M | $9.5M | $9.0M | $7.3M | $4.9M | $1.2M | $633.0K |
| Commercial Expense | $28.3M | $11.0M | $15.1M | $9.1M | $7.0M | $5.9M | $8.9M | $3.9M |
| Stock Issued During Period Value Stock Options Exercised | $444.0K | $53.0K | $189.0K | $420.0K | $121.0K | $300.0K | $44.0K | $461.0K |
| Prepaid Expense Current | $1.8M | $1.8M | $3.2M | $6.0M | $4.3M | $5.4M | $1.8M | $1.4M |
| Additional Paid In Capital | $64.1M | $39.6M | $33.8M | $24.4M | $15.7M | $8.5M | $3.8M | $2.7M |
| Class Of Warrant Or Right Outstanding | $16.4M | $12.9M | $9.6M | $8.5M | $12.3M | $11.4M | $0.00 | |
| Class Of Warrant Or Right Issued | $16.4M | $12.9M | $9.6M | $8.5M | $12.3M | $11.4M | $0.00 | |
| Warrants And Rights Outstanding | $55.6M | $53.1M | $48.5M | $34.4M | $52.9M | $48.0M | ||
| Warrants Issued During Period Value | $2.6M | $4.6M | $14.1M | $4.9M | $24.8M | |||
| Investment Income Interest | $2.9M | $4.2M | $4.0M | |||||
| Stock Issued During Period Value New Issues | $37.6M | $27.3M | $2.6M | $48.2M | $85.4M | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $300.0K | $191.0K | $393.0K | |||||
| Accretion Amortization Expense Of Investment Discount Or Premium | -$81.0K | -$454.0K | -$162.0K | -$97.0K | ||||
| Paid In Kind Interest | $3.4M | $3.2M | $2.3M | |||||
| Amortization Of Financing Costs And Discounts | $432.0K | $370.0K | $244.0K | |||||
| Stock Issued During Period Shares Stock Options Exercised | 33.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.3M | $1.3M | $1.4M | $1.4M | $1.4M | $1.5M | $2.9M | $2.5M | $2.3M | $2.4M | $2.4M | $2.1M | $2.0M | $1.9M | $1.4M | $1.3M | $1.2M | $981.0K | $350.0K | $276.0K | $211.0K | $85.0K | $79.0K | $125.0K |
| Commercial Expense | $4.6M | $5.1M | $10.4M | $1.9M | $1.8M | $2.9M | $4.4M | $3.4M | $2.4M | $2.7M | $2.2M | $1.6M | $1.6M | $1.8M | $1.4M | $905.0K | $1.5M | $2.2M | $2.1M | $2.2M | $2.2M | $1.2M | $375.0K | $725.0K |
| Stock Issued During Period Value Stock Options Exercised | $123.0K | $36.0K | $29.0K | $117.0K | $40.0K | $24.0K | $124.0K | $28.0K | $140.0K | $49.0K | $24.0K | $19.0K | $48.0K | $172.0K | $77.0K | $25.0K | $7.0K | $30.0K | ||||||
| Prepaid Expense Current | $2.6M | $748.0K | $2.4M | $2.5M | $1.7M | $2.4M | $7.0M | $5.4M | $5.4M | $5.1M | $3.5M | $4.1M | $6.0M | $7.4M | $6.3M | $3.5M | $6.1M | $1.6M | $3.5M | $5.0M | $5.5M | |||
| Additional Paid In Capital | $66.3M | $42.2M | $40.9M | $38.1M | $36.7M | $35.3M | $32.0M | $29.1M | $26.6M | $22.4M | $20.1M | $17.8M | $13.8M | $11.8M | $9.9M | $7.1M | $5.8M | $4.7M | $3.5M | $3.1M | $2.8M | |||
| Class Of Warrant Or Right Outstanding | $16.4M | $12.9M | $12.9M | $12.9M | $12.9M | $12.9M | $9.6M | $9.6M | $9.6M | $12.3M | $12.3M | $12.3M | $12.3M | $12.3M | $11.4M | $6.7M | ||||||||
| Class Of Warrant Or Right Issued | $12.9M | $12.9M | $9.6M | $12.3M | $11.4M | |||||||||||||||||||
| Warrants And Rights Outstanding | $55.6M | $53.1M | $53.1M | $53.1M | $53.1M | $53.1M | $48.5M | $48.5M | $48.5M | $52.9M | $52.9M | $52.9M | $52.9M | $52.9M | $48.0M | $24.8M | ||||||||
| Warrants Issued During Period Value | $2.6M | $4.6M | $14.1M | $2.0M | $4.9M | $24.8M | ||||||||||||||||||
| Investment Income Interest | $874.0K | $516.0K | $697.0K | $1.1M | $1.2M | $994.0K | $1.1M | $1.2M | $585.0K | $474.0K | $158.0K | |||||||||||||
| Stock Issued During Period Value New Issues | $23.1M | $27.3M | $2.6M | $85.4M | ||||||||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $159.0K | $140.0K | $74.0K | $117.0K | $265.0K | $128.0K | ||||||||||||||||||
| Accretion Amortization Expense Of Investment Discount Or Premium | -$81.0K | -$93.0K | -$50.0K | |||||||||||||||||||||
| Paid In Kind Interest | $833.0K | $785.0K | ||||||||||||||||||||||
| Amortization Of Financing Costs And Discounts | $102.0K | $87.0K | ||||||||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 18.2K | 37.7K |
Most recent annual filing with the SEC: March 20, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.